A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer.

[1]  G. Uzan,et al.  TNFR2 Is a Crucial Hub Controlling Mesenchymal Stem Cell Biological and Functional Properties , 2020, Frontiers in Cell and Developmental Biology.

[2]  B. Salomon,et al.  The TNF/TNFR2 signaling pathway is a key regulatory factor in endothelial progenitor cell immunosuppressive effect , 2020, Cell Communication and Signaling.

[3]  D. Faustman,et al.  TNFR2 blockade alone or in combination with PD‐1 blockade shows therapeutic efficacy in murine cancer models , 2020, Journal of leukocyte biology.

[4]  Zachary L. Skidmore,et al.  Rapid Progression of Adult T-Cell Leukemia/Lymphoma as Tumor Infiltrating Treg Cells after PD-1 Blockade. , 2019, Blood.

[5]  Fangxuan Li,et al.  CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis , 2019, Cancer medicine.

[6]  M. Feldmann,et al.  TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells , 2019, Proceedings of the National Academy of Sciences.

[7]  S. Sakaguchi,et al.  Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer. , 2019, Immunity.

[8]  J. Oppenheim,et al.  HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways , 2018, Front. Immunol..

[9]  M. Khodadoust,et al.  Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome , 2018, Leukemia.

[10]  D. Klatzmann,et al.  Regulatory T cells in the treatment of disease , 2018, Nature Reviews Drug Discovery.

[11]  Min Zhang,et al.  The Significance of Tumor Necrosis Factor Receptor Type II in CD8+ Regulatory T Cells and CD8+ Effector T Cells , 2018, Front. Immunol..

[12]  F. Pan,et al.  The regulation of immune tolerance by FOXP3 , 2017, Nature Reviews Immunology.

[13]  Xin Chen,et al.  Development of a Curative Therapeutic Vaccine (TheraVac) for the Treatment of Large Established Tumors , 2017, Scientific Reports.

[14]  R. Minter,et al.  Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy , 2016, Oncotarget.

[15]  C. Le,et al.  Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. , 2016, Blood.

[16]  A. Azmi,et al.  Immune evasion in cancer: Mechanistic basis and therapeutic strategies. , 2015, Seminars in cancer biology.

[17]  Hong-Chiang Chang,et al.  Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA‐541→androgen receptor (AR)→MMP9 signaling , 2015, Molecular oncology.

[18]  D. Männel,et al.  Myeloid suppressor cells require membrane TNFR2 expression for suppressive activity , 2014, Immunity, inflammation and disease.

[19]  A. Wei,et al.  Reducing TNF Receptor 2+ Regulatory T Cells via the Combined Action of Azacitidine and the HDAC Inhibitor, Panobinostat for Clinical Benefit in Acute Myeloid Leukemia Patients , 2013, Clinical Cancer Research.

[20]  George Coukos,et al.  T-regulatory cells: key players in tumor immune escape and angiogenesis. , 2012, Cancer research.

[21]  M. Bustin,et al.  High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses , 2012, The Journal of experimental medicine.

[22]  M. Gold,et al.  TNFR1 delivers pro‐survival signals that are required for limiting TNFR2‐dependent activation‐induced cell death (AICD) in CD8+ T cells , 2011, European journal of immunology.

[23]  A. Herbelin,et al.  The TLR7 Agonist R848 Alleviates Allergic Inflammation by Targeting Invariant NKT Cells To Produce IFN-γ , 2011, The Journal of Immunology.

[24]  Xin Chen,et al.  TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells. , 2010, Current directions in autoimmunity.

[25]  Edward Y. Kim,et al.  TNFR2-Deficient Memory CD8 T Cells Provide Superior Protection against Tumor Cell Growth1 , 2009, The Journal of Immunology.

[26]  D. Männel,et al.  Cutting Edge: Expression of TNFR2 Defines a Maximally Suppressive Subset of Mouse CD4+CD25+FoxP3+ T Regulatory Cells: Applicability to Tumor-Infiltrating T Regulatory Cells1 , 2008, The Journal of Immunology.

[27]  A. Godkin,et al.  Regulatory T cells and tumour immunity – observations in mice and men , 2007, Immunology.

[28]  P. Pandolfi,et al.  Downstream of Tyrosine Kinases-1 and Src Homology 2-Containing Inositol 5′-Phosphatase Are Required for Regulation of CD4+CD25+ T Cell Development1 , 2006, The Journal of Immunology.

[29]  S. Akira,et al.  TLR signalling and the function of dendritic cells. , 2005, Chemical immunology and allergy.

[30]  S. Akira,et al.  Toll-like Receptors and Their Signaling Mechanisms , 2003, Scandinavian journal of infectious diseases.